step 5 semaglutide 5: improves short- and longer-term control of eating with weight loss Weight regain and cardiometabolic effects
Description
A UNC Health endocrinologist explains the long-term effects on hunger and weight.

GLP-1 is having a cultural momentbut it's been quietly shaping metabolic health research for decades

As we approach launch, Zach is looking for a CTO / technical co-founder to help scale the platform

Now Im reentering a world I once shut myself off from.

The #FDA approved the first oral GLP-1 receptor agonist, semaglutide (#Wegovy pill), for chronic weight management in adults with obesity or overweight with comorbidities, offering a noninjectable alternative with significant weight loss benefits

For best results, take with a meal
